MCL coexpression mm9:1175: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0005409!3.09e-13!47;UBERON:0000160!4.96e-11!31;UBERON:0004923!4.51e-10!24;UBERON:0004119!2.61e-09!118;UBERON:0000925!2.61e-09!118;UBERON:0006595!2.61e-09!118;UBERON:0001007!1.35e-08!116;UBERON:0001555!1.35e-08!116;UBERON:0007026!1.35e-08!116;UBERON:0000344!2.75e-08!15;UBERON:0004921!8.50e-08!114;UBERON:0001242!4.47e-07!13;UBERON:0000060!4.47e-07!13;UBERON:0001262!4.47e-07!13;UBERON:0004786!4.47e-07!13 | |ontology_enrichment_uberon=UBERON:0005409!3.09e-13!47;UBERON:0000160!4.96e-11!31;UBERON:0004923!4.51e-10!24;UBERON:0004119!2.61e-09!118;UBERON:0000925!2.61e-09!118;UBERON:0006595!2.61e-09!118;UBERON:0001007!1.35e-08!116;UBERON:0001555!1.35e-08!116;UBERON:0007026!1.35e-08!116;UBERON:0000344!2.75e-08!15;UBERON:0004921!8.50e-08!114;UBERON:0001242!4.47e-07!13;UBERON:0000060!4.47e-07!13;UBERON:0001262!4.47e-07!13;UBERON:0004786!4.47e-07!13 | ||
|tfbs_overrepresentation_for_novel_motifs=1.11639,1.45672,0.411716,0.480627,0.299217,0.495263,0.587291,0.594722,0.215218,0.478312,0.542749,0.575086,0.206435,0.599731,0.315771,0,0.795315,0.291368,0.19222,0.731589,0.374752,1.47264,0.598814,0.29769,0.419327,0.62766,0.184473,0.516511,0.911169,0.876948,0.50223,0.897561,0.78719,0.498917,0.316253,1.97038,0.279977,0.57142,0.258564,0.652422,0.295233,0.507468,0.0742755,0.851774,0.277561,0.469348,1.70029,1.31862,0.219744,0.917701,0.777641,0.654933,0.431711,1.04034,1.0579,0.606984,0.356236,0.56214,0.176152,0.604914,0.877332,0.664501,0.642748,0.766235,0.618279,0.807219,1.19497,1.54543,0.872612,1.39786,1.01778,0.21183,0.0869413,1.09164,1.55661,0.482617,0.498755,0.703064,0.859987,0.378988,0.212973,0.812889,0.663039,0.200155,0.975495,3.54942,0.667407,0.447265,0.719558,1.70793,1.26498,0.980512,0.910485,0.305079,0.708155,0.237542,0.203879,0.913319,0.71485,0.79664,0.280055,0.897279,1.02279,0.778243,0.777175,1.26443,0.837607,0.528416,0.998363,0.376549,0.430942,1.02459,0.380122,0.547992,1.27206,0.293461,0.418498,0.484437,0.796633,0.276329,1.09707,0.745011,0.629509,0.702145,1.32639,0.863723,0.595563,0.903645,1.19345,0.308038,1.00568,0.473246,1.16374,0.620831,1.29374,0.0806013,0.446555,0.508896,1.24438,2.07659,1.67603,1.19971,0.641722,0.908128,0.770616,0.507927,0.717753,2.03691,0.448938,0.813943,1.42503,0.545091,1.04192,0.243291,0.619892,1.12411,0.655955,0.327731,0.435579,1.13413,1.25393,0.974632,0.864173,0.428662,0.767269,0.612377,0.763807,0.573477,1.86859 | |||
}} | }} | ||
Revision as of 19:30, 26 November 2012
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
| GO ID | GO name | FDR corrected p-value |
|---|---|---|
| GO:0030027 | lamellipodium | 0.00946547036280019 |
| GO:0031252 | leading edge | 0.0114244153791895 |
| GO:0030296 | protein tyrosine kinase activator activity | 0.0197200838402074 |
| GO:0015629 | actin cytoskeleton | 0.0295639229480919 |
| GO:0005856 | cytoskeleton | 0.0295639229480919 |
| GO:0005545 | phosphatidylinositol binding | 0.0295639229480919 |
| GO:0003779 | actin binding | 0.0325950479901803 |
| GO:0030295 | protein kinase activator activity | 0.0332457491844284 |
| GO:0019209 | kinase activator activity | 0.039386181975423 |
| GO:0008092 | cytoskeletal protein binding | 0.0429271196841837 |
| GO:0042995 | cell projection | 0.0461570015377674 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
| Ontology term | p-value | n |
|---|---|---|
| gastrointestinal system | 3.09e-13 | 47 |
| intestine | 4.96e-11 | 31 |
| organ component layer | 4.51e-10 | 24 |
| endoderm-derived structure | 2.61e-09 | 118 |
| endoderm | 2.61e-09 | 118 |
| presumptive endoderm | 2.61e-09 | 118 |
| digestive system | 1.35e-08 | 116 |
| digestive tract | 1.35e-08 | 116 |
| primitive gut | 1.35e-08 | 116 |
| mucosa | 2.75e-08 | 15 |
| subdivision of digestive tract | 8.50e-08 | 114 |
| intestinal mucosa | 4.47e-07 | 13 |
| anatomical wall | 4.47e-07 | 13 |
| wall of intestine | 4.47e-07 | 13 |
| gastrointestinal system mucosa | 4.47e-07 | 13 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
| Motifs | -log10(p-value) |
|---|---|
|
{{{tfbs_overrepresentation_jaspar}}} |
